🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Peter M. Ferguson

The University of Sydney

ORCID: 0000-0002-8335-0406

Also affiliated with New South Wales Department of Health, Royal Prince Alfred Hospital, Melanoma Institute Australia

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.386Author DataRank

Indexed papers

4in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma

PLoS ONE(2023)10.1371/journal.pone.0269324
Top 47%
0.386DataRank
Top 47%10 citations

Keimya Sadeghi, Sharon N. Edmiston, Jessica M. Kenney, Cecilia Lezcano, James S. Wilmott +47 more

Papers

Driven by 9 papers — median percentile 0. Top paper: “InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma”.

InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma

PLoS ONE(2023)10.1371/journal.pone.0269324
Top 47%
0.386DataRank
Top 47%10 citations

Keimya Sadeghi, Sharon N. Edmiston, Jessica M. Kenney, Cecilia Lezcano, James S. Wilmott +47 more

DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance

JCO Precision Oncology(2024)10.1200/po-24-00375
N/A
0.327DataRank · unranked
6 citations

Sharon N. Edmiston, Amanda M. Vondras, Allison Reiner, David L. Corcoran, Ronglai Shen +70 more

Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2581
N/A
0DataRank · unranked
17 citations

Hussein A. Tawbi, Johnathan A. Engh, Nduka Amankulor, Brindha Shivalingam, Hiya Banerjee +13 more

Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence

Nature Cancer(2020)10.1038/s43018-019-0019-5
N/A
0DataRank · unranked
43 citations

Julie Rytlewski, James S. Wilmott, Martín C. Mihm, Grace H. Attrill, Beatrice Dyring‐Andersen +12 more

Data from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases

(2023)10.1158/1078-0432.c.6533110.v1
Top 100%
0DataRank
Top 100%0 citations

Hussein A. Tawbi, Johnathan A. Engh, Nduka Amankulor, Brindha Shivalingam, Hiya Banerjee +13 more

InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma

UNC Libraries(2023)10.17615/btmj-c685
Top 100%
0DataRank
Top 100%0 citations

R.A. Scolyer, C.B. Begg, Iman Osman, C Timothy Thompson, Elise K. Brunsgaard +48 more

Comprehensive mutational profiling identifies new driver events in cutaneous leiomyosarcoma

British Journal of Dermatology(2024)10.1093/bjd/ljae386
N/A
0DataRank · unranked
9 citations

Martin Del Castillo Velasco‐Herrera, Saamin Cheema, Kim Ping Wong, Jacqueline Marcia Boccacino, Victoria Offord +19 more

Data from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases

(2023)10.1158/1078-0432.c.6533110
Top 100%
0DataRank
Top 100%0 citations

Hussein A. Tawbi, Johnathan A. Engh, Nduka Amankulor, Brindha Shivalingam, Hiya Banerjee +13 more

Histopathological features of complete pathological response predict recurrence-free survival following neoadjuvant targeted therapy for metastatic melanoma

Annals of Oncology(2020)10.1016/j.annonc.2020.07.016
N/A
0DataRank · unranked
35 citations

Chandra Mani Adhikari, Serigne Lo, Robert V. Rawson, Rodabe N. Amaria, Alexander M. Menzies +16 more